X @Bloomberg
Bloomberg·2025-08-06 15:55
Mergers and Acquisitions - Novartis is considering acquiring Avidity Biosciences to strengthen its drug pipeline [1] - Avidity Biosciences focuses on rare diseases [1]
Mergers and Acquisitions - Novartis is considering acquiring Avidity Biosciences to strengthen its drug pipeline [1] - Avidity Biosciences focuses on rare diseases [1]